** Shares of British food ingredients maker Tate & Lyle TATE.L up 2.6% at 533p
** UBS Global Research initiates coverage on TATE with "neutral"
** PT of 590p, representing an 10.69% upside to stock's last close
** Brokerage sees "lack of acceleration" in volume growth in FY26, and expects limited upside to consensus estimates for FY26 and FY27
** UBS expects weaker organic sales growth versus peers (like Kerry Group Plc KYGa.I and Ingredion Inc INGR.N) and fragile U.S. consumer confidence, where co has high exposures
** Average rating of 10 analysts is "buy"; median PT is 745p — data compiled by LSEG
** As of last close, stock down ~18.4% YTD
(Reporting by Akriti Shah in Bengaluru)
((akriti.shah@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.